Back to top

$SPRY stock is down 28% today. Here's what we see in our data.

$SPRY stock has now fallen 28% today, according to our price data from Polygon. There has been approximately $16,575,383 of trading volume.

It has been the 649th most-searched ticker on Quiver Quantitative over the last day, out of 13,119 total tickers searched.

Here is what we see in our data on $SPRY (you can track the company live on Quiver's $SPRY stock page):

$SPRY Insider Trading Activity

SPRY Insider Trades

$SPRY insiders have traded $SPRY stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $SPRY stock by insiders over the last 6 months:

  • ERIC KARAS (Chief Commercial Officer) sold 25,000 shares for an estimated $250,000
  • ALEXANDER A FITZPATRICK (Chief Legal Officer) sold 3,355 shares for an estimated $33,550

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$SPRY Hedge Fund Activity

We have seen 99 institutional investors add shares of $SPRY stock to their portfolio, and 103 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

EARLY ACCESS
Receive SPRY Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

You can track data on $SPRY on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ARS Pharmaceuticals, Inc. (SPRY)